Navigation Links
Axial Biotech Names New VP of Reimbursement and Regulatory Affairs
Date:8/29/2008

Experienced Executive Rina Wolf Well-Positioned to Help Drive Company

Growth

SALT LAKE CITY, Aug. 29 /PRNewswire/ -- Axial Biotech, Inc., a company poised to revolutionize spine care through the development of molecular diagnostic and motion preserving technologies, announced today that it has named Rina Wolf as the company's new Vice President of Reimbursement and Regulatory Affairs.

In her new role, Wolf will be responsible for the creation and implementation of reimbursement strategies and policies. As Axial's liaison to the laboratory community, she will continue her active role in matters relating to reimbursement and regulatory initiatives that impact molecular diagnostics.

John Climaco, President and CEO of Axial Biotech, stated, "One of the key components of Axial's future success will be achieving appropriate levels of insurance coverage for our products and Ms. Wolf's vast experience in this area is second to none. In addition, she brings to our company an unparalleled level of understanding of the complex and rapidly evolving regulatory landscape around molecular diagnostics."

In her most recent role as VP of Reimbursement and Regulatory Affairs with RedPath Integrated Pathology, Wolf was responsible for creating and managing all billing polices and activities, patient advocacy programs, and public/private payer coverage and contracting. This included gaining a favorable Coverage Article for PathFinderTG(R) with RedPath's MAC.

Prior to joining RedPath, Wolf was the Director of Reimbursement and Payer Relations for Genomic Health, Inc. where she helped to develop reimbursement strategies and programs that led to positive coverage policies with major third party payers, as well as a favorable local coverage determination from Genomic Health's Part B Medicare Carrier.

Wolf has also worked at Esoterix (now LabCorp) as Vice President of Contracts, and has worked at both Scheri
'/>"/>

SOURCE Axial Biotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Axial Biotech Meets Major Scientific Milestones; Receives $6 Million Tranche of Series B Financing
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the 2008 NewsMakers In the Biotech Industry Conference
4. BioSpace and BayBio announce 2008-2009 Biotech Bay(TM) Hotbed Campaign
5. Start-Up and Emerging Biotech Companies Will Tell Their Stories at Biosciences Showcase Planned for MichBio Expo
6. Nile Therapeutics to Present at BioCenturys NewsMakers in the Biotech Industry Conference
7. Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation
9. USDA Approves Syngenta and John Deere for Broadened Biotechnology Endorsement for Corn Crop Insurance
10. DuPont Obtains Biotechnology Endorsement for Pioneer(R) Brand Products
11. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for Cancer Therapy Based on Targeting a Biomarker by Novel Investigational Agents

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...AI,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxyannounc...)hasapprovedthe,investigationalnewdrugapplication(...insulinformulationtotreatdiabetes.ThisIND,approval.... , Diabetesisadisordercharacteristicofhighbl...betesoftenresultinseveremicro-and,macro-vasculardi...
(Date:11/24/2009)... The FBI recently approved the Promega ...ticipating in or generating DNA records for the Na... Madison, WI USA (PRWEB) -- The FBI recently appr... use by laboratories participating in, or generati...(NDIS). NDIS currently contains more than seven mi...
(Date:11/24/2009)...TURE:HTL , TORONTO,Nov.24/PRNewswire-FirstCal...pitalInc.,aleadingproviderofadvancedlasersystemsan...icmarkets,todayreportedoperationalandfinancialresu...2009Highlights,-Revenuewas$1.46millioncomparedwit...centcomparedwith66.1percentinQ3,2008,-Netlossreduc...
(Date:11/24/2009)...GO,Nov.24,2009/PRNewswire-FirstCall/--ArenaPharmac...ecompanyisscheduledtopresentatthePiperJaffray21stA...m.EasternTime(8:30a.m.PacificTime)attheNewYorkPala...dChiefExecutiveOfficer,isscheduledtoprovideanoverv...discoveryprograms. ,, Aliveaudiowebcastofthepre...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...ome of the world,s most respected energy experts w...ons during a daylong gathering in Houston, the Ene...artnership once again takes center stage in leadin...merica,s Energy Future: Assessing Our Paths to Ene...ston (PRWEB) March 13, 2009 -- President Obama rec...
...ference Call on Friday, March 13, 2009 at 8:30am E...als, Inc. (Nasdaq: KERX ), a biopharmaceutical c... commercialization of medically important, novel p...hreatening diseases, including renal disease and c... for the fourth quarter and year ended December 31...
...d Burrill & Company Collaborating on Strategic...ISLAND, Minn., March 12 Developer Tower Investmen...iences firm Burrill & Company ("Burrill") toda...ncing plans for the Elk Run master planned develop...Business Park at Elk Run. , , Tower and Burrill ...
Other Biology Technology:Greater Houston Partnership to Lead Energy Security Discussion 2Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2008 Financial Results 2Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2008 Financial Results 3Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2008 Financial Results 4Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2008 Financial Results 5Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2008 Financial Results 6Elk Run Developers Announce Partnership with Leading Life Sciences Firm 2Elk Run Developers Announce Partnership with Leading Life Sciences Firm 3Elk Run Developers Announce Partnership with Leading Life Sciences Firm 4
(Date:11/24/2009)...a matter of debate. A high-profile study a few yea...f their carbon from trees and leaves, evidence for...atic ecosystems. , But new research from the Uni...be true. Algae provide a much richer diet for fish...lished this week in the Proceedings of the Nation...
(Date:11/23/2009)...23, 2009 Applied mathematicians dissected the mor... a characteristic long leaf with a saddle-like arc...dges. The simple cause of the lily,s fan-like shap...differential growthwas revealed by using an equall...aiyi Liang, a postdoctoral student at Harvard,s Sc...
(Date:11/23/2009)...provides "incontrovertible evidence" that the volc...ra about 73,000 years ago deforested much of centr...earchers report. , The volcano ejected an estima...e, leaving a crater (now the world,s largest volca...eters wide. Ash from the event has been found in I...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3The cause behind the characteristic shape of a long leaf revealed 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 14742 1Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 14742 2Transgenomic Inc Reports Third Quarter 2009 Results 14739 1Transgenomic Inc Reports Third Quarter 2009 Results 14739 2Transgenomic Inc Reports Third Quarter 2009 Results 14739 3Transgenomic Inc Reports Third Quarter 2009 Results 14739 4Transgenomic Inc Reports Third Quarter 2009 Results 14739 5Transgenomic Inc Reports Third Quarter 2009 Results 14739 6Transgenomic Inc Reports Third Quarter 2009 Results 14739 7ARKRAY Inc Receives FDA Clearance for New GLUCOCARD 28R 29 Vital 28TM 29 Blood Glucose Monitoring System 6035 1ARKRAY Inc Receives FDA Clearance for New GLUCOCARD 28R 29 Vital 28TM 29 Blood Glucose Monitoring System 6035 2
... for assessing environmental contamination after o...ons where it doesn,t work and might produce false ...ic Institution (WHOI) has warned. , Private firm...ing long strands of absorbent polypropylene snares...ntamination of the seafloor in the wake of an oil ...
...lif.-- A naturally occurring molecule made by symb...nt for inflammatory bowel disease, according to sc.... , "Most people tend to think of bacteria as in...rkis K. Mazmanian, an assistant professor of biolo...otic relationship between "good" bacteria and thei...
... Oslo SEVEN pioneering scientists who have trans...e, neuroscience and astrophysics have become the f.... , The laureates were selected for their groundb...ur understanding of the unusual properties of matt... the human brain and the nature of quasars. , The...
Other Biology News:Marine chemist says 'not so fast' to quick oil detection method 2Getting better with a little help from our 'micro' friends 2Getting better with a little help from our 'micro' friends 3Names of inaugural Kavli Prize winners revealed 2Names of inaugural Kavli Prize winners revealed 3
Mouse Anti-Yersinia pestis Monoclonal Antibody, Unconjugated, Clone YPF19 from Abcam
Rabbit Anti-13,14 dihydro 15 keto Prostaglandin E2 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Human DDO Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Anti-Arginine Vasopressin Receptor Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: